Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion. (31st January 2012)

• Record Type: Journal Article
• Authors: Nagpal, Manish; Mehta, Vikram; Nagpal, Kamal
• Other Names: Roberts D. K. Academic Editor.
• Is Part Of: Case reports in ophthalmological medicine. Volume 2011(2011)
• Publication Date: 2012-01-31
• Subjects: Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Ophthalmology; Eye Diseases; Eye -- Diseases; Ophthalmology; Electronic journals; Periodicals; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 617.7
• DOI: 10.1155/2011/679751
• Languages: English
• ISSNs: 2090-6722

Abstract

Abstract : Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case, a full-thickness macular hole was noticed one month after intravitreal bevacizumab for macular edema secondary to hemicentral retinal vein occlusion. On a detailed review of the pre- and postoptical coherence tomography scans, it was realized that there was a preexisting stage 2-3 macular hole which was masked by the hemorrhages and edema at the fovea and the macular hole had progressed following the injection.